Estimating Survival Time of Patients With Glioblastoma Multiforme and Characterization of the Identified microRNA Signatures

BMC Genomics - United Kingdom
doi 10.1186/s12864-016-3321-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

20 Disparities in Survival for Patients With Glioblastoma Multiforme

Canadian Journal of Neurological Sciences
MedicineNeurology
2018English

A Multivariate Analysis of 416 Patients With Glioblastoma Multiforme: Prognosis, Extent of Resection, and Survival

Journal of Neurosurgery
SurgeryNeurology
2001English

The Spectrum of Vaccine Therapies for Patients With Glioblastoma Multiforme

Current Treatment Options in Oncology
OncologyPharmacology
2012English

Expression of S1P Metabolizing Enzymes and Receptors Correlate With Survival Time and Regulate Cell Migration in Glioblastoma Multiforme

Oncotarget
Oncology
2016English

A Genetic Survival Network for Glioblastoma Multiforme

Genome Biology
2011English

Effect of Anti-Epileptic Drugs on the Survival of Patients With Glioblastoma Multiforme: A Retrospective, Single-Center Study

PLoS ONE
Multidisciplinary
2019English

Identification of a Multidimensional Transcriptome Signature for Survival Prediction of Postoperative Glioblastoma Multiforme Patients

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Cellular-Based Immunotherapies for Patients With Glioblastoma Multiforme

Clinical and Developmental Immunology
2012English

Identification of a NFKBIA Polymorphism Associated With Lower NFKBIA Protein Levels and Poor Survival Outcomes in Patients With Glioblastoma Multiforme

International Journal of Molecular Medicine
MedicineGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy